首页>
外国专利>
METHOD FOR PREVENTING OBSTETRICAL COMPLICATION IN PREGNANT WOMEN WITH REPLICATION OF HEPATITIS VIRUS B DETECTED FOR THE FIRST TIME
METHOD FOR PREVENTING OBSTETRICAL COMPLICATION IN PREGNANT WOMEN WITH REPLICATION OF HEPATITIS VIRUS B DETECTED FOR THE FIRST TIME
展开▼
机译:用首次检测到的乙型肝炎病毒复制防止孕妇妊娠结局的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The method for preventing obstetrical complication in pregnant women with replication of hepatitis virus B detected for the first time comprises the use of Proteflasid in the course of gestation. The preparation is prescribed starting from the first day when the acute viral hepatitis B was diagnosed, first at a dose of 5 drops thrice a day for three days and later û 10 drops thrice a day, until the whole flask of the drug (30 mL) is used (in the case when the replication of hepatitis virus B was detected until Week 32 of gestation). The second flask is prescribed starting from Week 36 of gestation û 10 drops thrice a day. When the acute hepatitis B is diagnosed after Week 32 of gestation, the drug is prescribed at a dose of 5 drops thrice a day for three days and later û 10 drops thrice a day.
展开▼
机译:首次检测到乙型肝炎病毒复制的孕妇预防产科并发症的方法包括在妊娠过程中使用Proteflasid。从诊断出急性乙型肝炎的第一天开始,开始处方处方,首先以每天5滴的剂量连续3天每天三次,然后每天û10滴,直到整瓶药物(30 mL )(在怀孕第32周之前检测到乙型肝炎病毒复制的情况下)。从妊娠的第36周开始,开第二瓶–每天三次10滴。当在妊娠第32周后诊断出急性乙型肝炎时,该药的处方为每天3次,每天5滴,连续3天,每次10滴。
展开▼